These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10070236)

  • 1. [Prevention of venous thrombosis: role of heparins].
    Wahl D; Lepaux DJ; Piquemal R; Frédéric M; Cayrol C; Lecompte T; Thibaut G
    Therapie; 1998; 53(6):575-8. PubMed ID: 10070236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
    Hirmerová J
    Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.
    Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H
    Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the risk of venous thromboembolism in the medical patients].
    Mismetti P; Juillard-Delsart D; Tardy B; Laporte-Simitsidis S; Decousus H
    Therapie; 1998; 53(6):565-70. PubMed ID: 10070234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thromboembolism.
    Pini M; Spyropoulos AC
    Semin Thromb Hemost; 2006 Nov; 32(8):755-66. PubMed ID: 17171588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
    Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
    Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin].
    Thilly N; Pierson H; Collard C; Lecompte T; Dufay E
    Therapie; 1998; 53(6):579-86. PubMed ID: 10070237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
    Bergqvist D
    Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
    Vergouwen MD; Roos YB; Kamphuisen PW
    Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.
    Motsch J; Walther A; Bock M; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW
    Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.